Observational Study of Vision Improvement in Late Stage Dry AMD Patients

The purpose of this study is to assess the vision improvement achieved by patients with late stage dry age-related macular degeneration who received corneal treatments by a low vision aid device. Patient records for patients with at least 12 months follow-up will be analyzed to determine measures of vision improvement including best spectacle-corrected distance and near visual acuity. Analyses will include descriptive statistics and correlation between outcomes and baseline characteristics.

Inclusion criteria

• - Male or female
• - Any race
• - Patient is at least 50 years old
• - Patient has diagnosed late stage dry age-related macular degeneration in one or both eyes.
• - Treated eyes were pseudophakic at the time of treatment.
• - Patient had moderate to severe baseline vision impairment with best spectacle-corrected distance visual acuity (CDVA) of 20/63 or worse (decimal = 0.317 or less; logMAR greater than or equal to 0.50) in the treated eye(s).
• - Patient CDVA records are available at baseline and at 12 month post-treatment.

Exclusion criteria

• - Corneal disease or disorder in either eye.
• - Increased intraocular pressure (above 20 mm Hg), glaucoma or history of glaucoma.
• - Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study.

-